Skip to main content
SpringerLink
Log in

Control of ACTH secretion by excitatory amino acids

Functional significance and clinical implications

  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The involvement of excitatory amino acids in the control of ACTH release is well established. Activation of ionotropic glutamate receptors has a stimulatory effect on ACTH release, while the role of metabotropic receptors is not yet understood in detail. Glutamatergic regulation of ACTH release has a clear significance for the stress response and neuroendocrine functions during development. A dysregulation of the hypothalamic-pituitary-adrenocortical (HPA) axis has been reported in several psychiatric and neurological disorders. So far, only fractional indices on the clinical importance of the interaction between glutamate and ACTH secretion have been obtained in both preclinical and clinical studies. Some antidepressant drugs, such as tianeptine, which were found to modulate ACTH release, appear to interfere with brain glutamatergic system. Changes in ACTH and cortisol release may be of importance for mood stabilizing effects of antiepileptic drugs modulating glutamate release, such as lamotrigine. Brain glutamate and HPA axis interaction seems to be of importance in alcohol and drug abuse. Little information is available on ACTH release in response to glutamate-modulating drugs used in the treatment of schizophrenia and Alzheimer disease. Nevertheless, pharmacological interventions influencing interaction between glutamate and the HPA axis are promising treatment possibilities in psychiatry and neurology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Makara, G. B. and Stark, E. (1975). Neuroendocrinology 18, 213–216.

    PubMed  CAS  Google Scholar 

  2. Gay, V. L. and Plant, T. M. (1987). Endocrinology 120, 2289–2296.

    PubMed  CAS  Google Scholar 

  3. Farah, J. M. Jr., Rao, T. S., Mick, S. J., Coyne, K. E., and Iyengar, S. (1991). Endocrinology 128, 1875–1880.

    PubMed  CAS  Google Scholar 

  4. Jezova, D., Oliver, C., and Jurcovicova, J. (1991). Neuroendocrinology 54, 488–492.

    PubMed  CAS  Google Scholar 

  5. Yousef, K. A., Tepper, P. G., Molina, P. E., Abumrad, N. N., and Lang, C. H. (1994). Brain Res. 634, 131–140.

    Article  PubMed  CAS  Google Scholar 

  6. Pechnick, R. N., George, R., and Poland, R. E. (1989). Eur. J. Pharmacol. 164, 257–263.

    Article  PubMed  CAS  Google Scholar 

  7. Jezova, D., Tokarev, D., and Rusnak, M. (1995). Neuroendocrinology 62, 326–332.

    PubMed  CAS  Google Scholar 

  8. Pechnick, R. N. and Poland, R. E. (2004). J. Pharmacol. Exp. Ther. 309, 515–522.

    Article  PubMed  CAS  Google Scholar 

  9. Tokarev, D. and Jezova, D. (1997). Methods Find. Exp. Clin. Pharmacol. 19, 323–328.

    PubMed  CAS  Google Scholar 

  10. Zelena, D., Makara, G. B., and Jezova, D. (1999). Neuroendocrinology 69, 316–323.

    Article  PubMed  CAS  Google Scholar 

  11. Broadbear, J. H., Winger, G., and Woods, J. H. (2004). Psychopharmacology (Berlin) 176, 398–406.

    Article  CAS  Google Scholar 

  12. Lang, C. H. and Ajmal, M. (1995). Am. J. Physiol. 268, R1026-R1033.

    PubMed  CAS  Google Scholar 

  13. Johnson, M. P., Kelly, G., and Chamberlain, M. (2001). J. Neuroendocrinol. 13, 670–677.

    Article  PubMed  CAS  Google Scholar 

  14. Scaccianoce, S., Matrisciano, F., Del Bianco, P., et al. (2003). Neuropharmacology 44, 555–561.

    Article  PubMed  CAS  Google Scholar 

  15. Bradbury, M. J., Giracello, D. R., Chapman, D. F., et al. (2003). Neuropharmacology 44, 562–572.

    Article  PubMed  CAS  Google Scholar 

  16. Aubry, J. M., Bartanusz, V., Pagliusi, S., Schulz, P., and Kiss, J. Z. (1996). Neurosci. Lett. 205, 95–98.

    Article  PubMed  CAS  Google Scholar 

  17. Herman, J. P., Eyigor, O., Ziegler, D. R., and Jennes, L. (2000). J. Comp. Neurol. 422, 352–362.

    Article  PubMed  CAS  Google Scholar 

  18. Kocsis, K., Kiss, J., Gorcs, T., and Halasz, B. (1998). Neuroreport 9, 4029–4033.

    Article  PubMed  CAS  Google Scholar 

  19. Herman, J. P., Mueller, N. K., and Figueiredo, H. (2004). Ann. NY Acad. Sci. 1018, 35–45.

    Article  PubMed  CAS  Google Scholar 

  20. Hrabovszky, E., Wittmann, G., Turi, G. F., Liposits, Z., and Fekete, C. (2005). Endocrinology 146, 341–347.

    Article  PubMed  CAS  Google Scholar 

  21. Joanny, P., Steinberg, J., Oliver, C., and Grino, M. (1997). J. Neuroendocrinol. 9, 93–97.

    Article  PubMed  CAS  Google Scholar 

  22. Zelena, D., Mergl, Z., and Makara, G. B. (2005). Brain Res. 1031, 185–193.

    Article  PubMed  CAS  Google Scholar 

  23. Jezova, D., Vigas, M., Bartanusz, V., Reymond, M. J., and Zorad, S. (1996). In: Stress: molecular genetic and neurobiological advances. McCarty, R., Aguilera, G., Sabban, E., and Kvetnansky R. (eds.). Gordon and Breach Science Publishers: New York, pp. 417–430.

    Google Scholar 

  24. Jezova, D. and Schwendt, M. (2005). In: Glutamate receptors in peripheral tissue: excitatory transmission outside the CNS. Gill, S. and Pulido O. (eds.). Kluwer Academic/Plenum Publishers: New York, pp. 169–178.

    Chapter  Google Scholar 

  25. Lowy, M. T., Gault, L., and Yamamoto, B. K. (1993). J. Neurochem. 61, 1957–1960.

    Article  PubMed  CAS  Google Scholar 

  26. Moghaddam, B. (1993). J. Neurochem. 60, 1650–1657.

    Article  PubMed  CAS  Google Scholar 

  27. Bartanusz, V., Aubry, J. M., Pagliusi, S., Jezova, D., Baffi, J., and Kiss, J. Z. (1995). Neuroscience 66, 247–252.

    Article  PubMed  CAS  Google Scholar 

  28. Fitzgerald, L. W., Ortiz, J., Hamedani, A. G., and Nestler, E. J. (1996). J. Neurosci. 16, 274–282.

    PubMed  CAS  Google Scholar 

  29. Schwendt, M. and Jezova, D. (2000). Cell. Mol. Neurobiol. 20, 319–329.

    Article  PubMed  CAS  Google Scholar 

  30. Akinbami, M. A., Philip, G. H., Sridaran, R., Mahesh, V. B., and Mann, D. R. (1999). J. Steroid Biochem. Mol. Biol. 70, 143–149.

    Article  PubMed  CAS  Google Scholar 

  31. Reagan, L. P., Rosell, D. R., Wood, G. E., et al. (2004). Proc. Natl. Acad. Sci. USA 101, 2179–2184.

    Article  PubMed  CAS  Google Scholar 

  32. Boudouresque, F., Chautard, T., Jezova, D., et al. (1991). Endocr. Regul. 25, 44–52.

    PubMed  CAS  Google Scholar 

  33. Skultetyova, I., Tokarev, D. I., and Jezova, D. (1993). Endocr. Regul. 27, 209–213.

    PubMed  CAS  Google Scholar 

  34. Olney, J. W. (1969). Science 164, 719–721.

    Article  PubMed  CAS  Google Scholar 

  35. Skultetyova, I., Kiss, A., and Jezova, D. (1998). Neuroendocrinology 67, 412–420.

    Article  PubMed  CAS  Google Scholar 

  36. Leret, M. L., Peinado, V., Suarez, L. M., Tecedor, L., Gamallo, A., and Gonzalez, J. C. (2004). Int. J. Dev. Neurosci. 22, 87–93.

    Article  PubMed  CAS  Google Scholar 

  37. Chautard, T., Boudouresque, F., Guillaume, V., and Oliver, C. (1993). Neuroendocrinology 57, 70–78.

    PubMed  CAS  Google Scholar 

  38. Kent, S., Kernahan, S. D., and Levine, S. (1996). Brain Res. Dev. Brain Res. 94, 1–13.

    Article  PubMed  CAS  Google Scholar 

  39. Jezova, D., Kiss, A., Tokarev, D., and Skultetyova, I. (1998). Stress Med. 14, 255–260.

    Article  Google Scholar 

  40. Makatsori, A., Dubovicky, M., Ujhazy, E., Bakos, J., and Jezova, D. (2005). Neurotoxicol. Teratol. 27, 509–514.

    Article  PubMed  CAS  Google Scholar 

  41. Jezova, D., Skultetyova, I., Makatsori, A., Moncek, F., and Duncko, R. (2002). Stress 5, 177–183.

    Article  PubMed  CAS  Google Scholar 

  42. Bakos, J., Duncko, R., Makatsori, A., Pirnik, Z., Kiss, A., and Jezova, D. (2004). Ann. NY Acad. Sci. 1018, 281–287.

    Article  PubMed  CAS  Google Scholar 

  43. Kendell, S. F., Krystal, J. H., and Sanacora, G. (2005). Expert. Opin. Ther. Targets 9, 153–168.

    Article  PubMed  CAS  Google Scholar 

  44. Tichomirowa, M. A., Keck, M. E., Schneider, H. J., et al. (2005). J. Endocrinol. Invest. 28, 89–99.

    PubMed  CAS  Google Scholar 

  45. Stahl, S. M. and Grady, M. M. (2003). J. Clin. Psychiatry 64 (Suppl. 13), 13–17.

    PubMed  CAS  Google Scholar 

  46. Duncko, R., Schwendt, M., and Jezova, D. (2003). Pharmacol. Biochem. Behav. 76, 9–16.

    Article  PubMed  CAS  Google Scholar 

  47. Strohle, A. and Holsboer, F. (2003). Pharmacopsychiatry 36 (Suppl. 3), S207-S214.

    PubMed  Google Scholar 

  48. Reid, I. C. and Stewart, C. A. (2004). Neurotox. Res. 6, 483–489.

    Article  PubMed  Google Scholar 

  49. McEwen, B. S. and Olie, J. P. (2005). Mol. Psychiatry 10, 525–537.

    Article  PubMed  CAS  Google Scholar 

  50. Delbende, C., Tranchand, B. D., Tarozzo, G., et al. (1994). Eur. J. Pharmacol. 251, 245–251.

    Article  PubMed  CAS  Google Scholar 

  51. Jezova, D. and Duncko, R. (2002). J. Psychopharmacol. 16, 235–240.

    PubMed  CAS  Google Scholar 

  52. Du, J., Gray, N. A., Falke, C. A., et al. (2004). J. Neurosci. 24, 6578–6589.

    Article  PubMed  CAS  Google Scholar 

  53. Zarate, C. A. Jr., Quiroz, J. A., Singh, J. B., et al. (2005). Biol. Psychiatry 57, 430–432.

    Article  PubMed  CAS  Google Scholar 

  54. Kniest, A., Wiesenberg, C., Weber, B., Colla, M., Heuser, I., and Deuschle, M. (2001). Neuropsychobiology 43, 91–95.

    Article  PubMed  CAS  Google Scholar 

  55. Makatsori, A., Duncko, R., Moncek, F., Loder, I., Katina, S., and Jezova, D. (2004). Neuroendocrinology 79, 34–42.

    Article  PubMed  CAS  Google Scholar 

  56. Pistovcakova, J., Makatsori, A., Sulcova, A., and Jezova, D. (2005). Eur. Neuropsychopharmacol. 15, 153–158.

    Article  PubMed  CAS  Google Scholar 

  57. Tzschentke, T. M. and Schmidt, W. J. (2003). Mol. Psychiatry 8, 373–382.

    Article  PubMed  CAS  Google Scholar 

  58. Schmidt, E. D., Tilders, F. J., Janszen, A. W., Binnekade, R., De Vries, T. J., and Schoffelmeer, A. N. (1995). Eur. J. Pharmacol. 285, 317–321.

    Article  PubMed  CAS  Google Scholar 

  59. Jezova, D., Mlynarik, M., Zelena, D., and Makara, G. B. (2004). Brain Res. 1021, 63–68.

    Article  PubMed  CAS  Google Scholar 

  60. Kim, J. H., Austin, J. D., Tanabe, L., Creekmore, E., and Vezina, P. (2005). Eur. J. Neurosci. 21, 295–300.

    Article  PubMed  Google Scholar 

  61. Torres, G., Rivier, C., and Weiss, F. (1994). Brain Res. 656, 33–42.

    Article  PubMed  CAS  Google Scholar 

  62. Makatsori, A., Duncko, R., Schwendt, M., Moncek, F., Johansson, B. B., and Jezova, D. (2003). Psychoneuroendocrinology 28, 702–714.

    Article  PubMed  CAS  Google Scholar 

  63. Schwendt, M., Duncko, R., Makatsori, A., Moncek, F., Johansson, B. B., and Jezova, D. (2003). Neurochem. Res. 28, 653–657.

    Article  PubMed  CAS  Google Scholar 

  64. Nakagawa, T. and Satoh, M. (2004). Ann. NY Acad. Sci. 1025, 383–388.

    Article  PubMed  CAS  Google Scholar 

  65. Le Greves, P., Huang, W., Zhou, Q., Thornwall, M., and Nyberg, F. (1998). Eur. J. Pharmacol. 341, 161–164.

    Article  PubMed  Google Scholar 

  66. Zhu, H., Jang, C. G., Ma, T., Oh, S., Rockhold, R. W., and Ho, I. K. (1999). Eur. J. Pharmacol. 365, 47–54.

    Article  PubMed  CAS  Google Scholar 

  67. Pirnik, Z., Schwendt, M., and Jezova, D. (2001). Endocr. Regul. 35, 187–193.

    PubMed  CAS  Google Scholar 

  68. Nagy, J. (2004). Drugs 7, 339–350.

    CAS  Google Scholar 

  69. Scott, L. J., Figgitt, D. P., Keam, S. J., and Waugh, J. (2005). CNS Drugs 19, 445–464.

    Article  PubMed  CAS  Google Scholar 

  70. Zimmerman, U., Spring, K., Koller, G., Holsboer, F., and Soyka, M. (2004). Pharmacopsychiatry 37, 98–102.

    PubMed  CAS  Google Scholar 

  71. Elman, I., Lukas, S. E., Karlsgodt, K. H., Gasic, G. P., and Breiter, H. C. (2003). Psychopharmacol. Bull. 37, 84–89.

    PubMed  Google Scholar 

  72. McCullumsmith, R. E., Clinton, S. M., and Meador-Woodruff, J. H. (2004). Int. Rev. Neurobiol. 59, 19–45.

    Article  PubMed  CAS  Google Scholar 

  73. Javitt, D. C. (2004). Mol. Psychiatry 9, 984–997.

    Article  PubMed  CAS  Google Scholar 

  74. Zhang, X. Y., Zhou, D. F., Cao, L. Y., Wu, G. Y., and Shen, H. C. (2005). Neuropsychopharmacology 30, 1532–1538.

    Article  PubMed  CAS  Google Scholar 

  75. Altamura, A. C., Boin, F., and Maes, M. (1999). Eur. Neuropsychopharmacol. 10, 1–4.

    Article  PubMed  CAS  Google Scholar 

  76. Hynd, M. R., Scott, H. L., and Dodd, P. R. (2004). Neurochem. Int. 45, 583–595.

    Article  PubMed  CAS  Google Scholar 

  77. Farlow, M. R. (2004). Geriatrics 59, 22–27.

    PubMed  Google Scholar 

  78. Pascualy, M., Petrie, E. C., Brodkin, K., Peskind, E. R., Wilkinson, C. W., and Raskind, M. A. (2000). Biol. Psychiatry 48, 247–254.

    Article  PubMed  CAS  Google Scholar 

  79. Zhou, Y., Yuferov, V. P., Spangler, R., Maggos, C. E., Ho, A., and Kreek, M. J. (1998). Eur. J. Pharmacol. 352, 65–71.

    PubMed  CAS  Google Scholar 

  80. Hergovich, N., Singer, E., Agneter, E., et al. (2001). Neuropsychopharmacology 24, 590–593.

    Article  PubMed  CAS  Google Scholar 

  81. Murck, H., Struttmann, T., Czisch, M., Wetter, T., Steiger, A., and Auer, D. P. (2002). Neuropsychobiology 45, 120–123.

    Article  PubMed  CAS  Google Scholar 

  82. van Berckel, B. N., Lipsch, C., Gispen-de Wied, C., et al. (1998). Psychopharmacology (Berlin) 138, 190–197.

    Article  Google Scholar 

  83. Deuster, P. A., Faraday, M. M., Chrousos, G. P., and Poth, M. A. (2005). J. Clin. Endocrinol. Metab. 90, 4777–4783.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Pharmacological Neuroendocrinology, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Vlarska 3, 83306, Bratislava, Slovakia

    Daniela Jezova

Authors
  1. Daniela Jezova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniela Jezova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jezova, D. Control of ACTH secretion by excitatory amino acids. Endocr 28, 287–293 (2005). https://doi.org/10.1385/ENDO:28:3:287

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:28:3:287

Key Words

Search

Navigation